Literature DB >> 28569383

Atrial fibrillation, cognition and dementia: A review.

Summer Aldrugh1, Mayank Sardana2, Nils Henninger3,4, Jane S Saczynski5, David D McManus2.   

Abstract

Atrial fibrillation (AF) is one of the most common types of cardiac arrhythmia, particularly among older adults. AF confers a 5-fold risk for thromboembolic stroke as well as a 2-fold higher risk for congestive heart failure, morbidity, and mortality. Although stroke remains an important and impactful complication of AF, recent studies have shown that AF is independently associated with other neurological disorders, including cognitive impairment and dementia, even after adjusting for prior ischemic stroke. We performed a review of the published literature on the association between AF and cognitive status. Further, we reviewed studies investigating the underlying mechanisms for this association and/or reporting the impact of AF treatment on cognitive function. While most published studies demonstrate associations between AF and impaired cognition, no AF treatment has yet been associated with a reduced incidence of cognitive decline or dementia.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; anticoagulants; atrial fibrillation; cognitive decline; dementia; vascular dementia

Mesh:

Substances:

Year:  2017        PMID: 28569383      PMCID: PMC5783292          DOI: 10.1111/jce.13261

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  77 in total

1.  Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.

Authors:  Irene Marzona; Martin O'Donnell; Koon Teo; Peggy Gao; Craig Anderson; Jackie Bosch; Salim Yusuf
Journal:  CMAJ       Date:  2012-02-27       Impact factor: 8.262

2.  Association between atrial fibrillation and volumetric magnetic resonance imaging brain measures: Framingham Offspring Study.

Authors:  Ryan J Piers; Arvind Nishtala; Sarah R Preis; Charles DeCarli; Philip A Wolf; Emelia J Benjamin; Rhoda Au
Journal:  Heart Rhythm       Date:  2016-07-11       Impact factor: 6.343

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.

Authors:  Victoria Jacobs; Heidi T May; Tami L Bair; Brian G Crandall; Michael J Cutler; John D Day; Charles Mallender; Jeffrey S Osborn; Scott M Stevens; J Peter Weiss; Scott C Woller; T Jared Bunch
Journal:  Am J Cardiol       Date:  2016-05-05       Impact factor: 2.778

5.  Correlation between rates of brain atrophy and cognitive decline in AD.

Authors:  N C Fox; R I Scahill; W R Crum; M N Rossor
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

Review 6.  Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects.

Authors:  Kristopher J Swiger; Raoul J Manalac; Roger S Blumenthal; Michael J Blaha; Seth S Martin
Journal:  Mayo Clin Proc       Date:  2013-10-01       Impact factor: 7.616

7.  Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings.

Authors:  T K Tatemichi; M A Foulkes; J P Mohr; J R Hewitt; D B Hier; T R Price; P A Wolf
Journal:  Stroke       Date:  1990-06       Impact factor: 7.914

8.  Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts.

Authors:  Hrafnhildur Stefansdottir; David O Arnar; Thor Aspelund; Sigurdur Sigurdsson; Maria K Jonsdottir; Haukur Hjaltason; Lenore J Launer; Vilmundur Gudnason
Journal:  Stroke       Date:  2013-02-26       Impact factor: 7.914

9.  Role of ventricular rate response on dementia in cognitively impaired elderly subjects with atrial fibrillation: a 10-year study.

Authors:  Francesco Cacciatore; Gianluca Testa; Assunta Langellotto; Gianluigi Galizia; David Della-Morte; Gaetano Gargiulo; Agnese Bevilacqua; Maria Teresa Del Genio; Vincenzo Canonico; Franco Rengo; Pasquale Abete
Journal:  Dement Geriatr Cogn Disord       Date:  2012-09-12       Impact factor: 2.959

Review 10.  Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy.

Authors:  Shuko Takeda; Naoyuki Sato; Ryuichi Morishita
Journal:  Front Aging Neurosci       Date:  2014-07-29       Impact factor: 5.750

View more
  24 in total

Review 1.  Nucleic Acid Therapies for Ischemic Stroke.

Authors:  Nils Henninger; Yunis Mayasi
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  Associations Between Atrial Arrhythmias and Brain Amyloid Deposition: The ARIC-PET Study.

Authors:  Michelle C Johansen; Wendy Wang; Michael J Zhang; Alvaro Alonso; Dean F Wong; Rebecca F Gottesman; Lin Y Chen
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

4.  Neuropsychological Assessment and Screening in Heart Failure: a Meta-Analysis and Systematic Review.

Authors:  Eric J Connors; Alexander O Hauson; Brianna D Barlet; Sharis Sarkissians; Nicholas P Stelmach; Alyssa D Walker; Natasha M Nemanim; Kristina L Greenwood; Nicholas J Chesher; Scott C Wollman; Kenneth E Allen; Matthew G Hall; Christopher Flora-Tostado
Journal:  Neuropsychol Rev       Date:  2021-01-11       Impact factor: 7.444

Review 5.  Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations.

Authors:  Tuoyo O Mene-Afejuku; Monica Pernia; Uzoma N Ibebuogu; Shobhana Chaudhari; Savi Mushiyev; Ferdinand Visco; Gerald Pekler
Journal:  Curr Cardiol Rev       Date:  2019

6.  The association of atrial fibrillation and dementia incidence: a meta-analysis of prospective cohort studies.

Authors:  Dao-Shen Liu; Jing Chen; Wei-Ming Jian; Guang-Rong Zhang; Zhi-Rong Liu
Journal:  J Geriatr Cardiol       Date:  2019-03       Impact factor: 3.327

7.  Variation in VKORC1 Is Associated with Vascular Dementia.

Authors:  Jure Mur; Daniel L McCartney; Daniel I Chasman; Peter M Visscher; Graciela Muniz-Terrera; Simon R Cox; Tom C Russ; Riccardo E Marioni
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

8.  Correlates of deep brain stimulation consensus conference decision to treat primary dystonia.

Authors:  Lindsay Niccolai; Stephen L Aita; Harrison C Walker; Victor A Del Bene; Adam Gerstenecker; Dario Marotta; Meredith Gammon; Roy C Martin; Olivio J Clay; Michael Crowe; Kristen L Triebel
Journal:  Clin Neurol Neurosurg       Date:  2021-06-08       Impact factor: 1.885

9.  The association between relevant comorbidities and dementia in patients with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Kristina Sundquist
Journal:  Geroscience       Date:  2018-06-22       Impact factor: 7.713

Review 10.  Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review.

Authors:  Mozhu Ding; Chengxuan Qiu
Journal:  Curr Epidemiol Rep       Date:  2018-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.